Eli Lilly Kisunla bags marketing authorization in Great Britain to treat mild cognitive impairment, mild dementia due to Alzheimer's Disease Ruchika Sharma30 Oct 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing...
Eli Lilly appoints Thomas J Fuchs as Chief AI officer Ruchika Sharma10 Oct 2024 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced the appointment of Thomas J. Fuchs, Dr.sc., as its first chief AI officer, effective Oct. 21,...
Eli Lilly Kisunla approved in Japan for early Symptomatic Alzheimer's disease Ruchika Sharma25 Sept 2024 3:54 PM ISTIndianapolis: Eli Lilly and Company's has announced that the Ministry of Health, Labour and Welfare Japan has approved Kisunla (donanemab-azbt,...
Eli Lilly planning expansion of research centre in India: CEO David Ricks Ruchika Sharma24 Sept 2024 10:00 AM ISTNew York: Eli Lilly is planning the expansion of its research centre in India and will be partnering with other Indian companies. Eli Lilly CEO...
Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries Ruchika Sharma8 Sept 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand access to...
Eli Lilly to acquire Morphic for USD 3.2 billion Ruchika Sharma9 July 2024 11:28 AM ISTIndianapolis: Eli Lilly and Company and Morphic Holding, Inc. have announced a definitive agreement for Lilly to acquire Morphic, a...
Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease Ruchika Sharma3 July 2024 11:20 AM ISTIndianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
Obesity pill Orforglipron data expected in April 2025: Eli Lilly exec Ruchika Sharma11 Jun 2024 6:19 PM ISTLondon: Eli Lilly executive said that data from the late-stage trial of their experimental obesity pill, orforglipron, is anticipated to be...
No major concerns raised by USFDA staff on Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma7 Jun 2024 2:00 PM ISTLondon: FDA examination of trial data for Eli Lilly's investigational Alzheimer's drug Donanemab uncovered no red flags but did highlight safety...
Eli Lilly appoints Melissa Seymour as executive vice president of Global Quality Ruchika Sharma5 Jun 2024 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that Melissa Seymour will join the company as executive vice president of Global Quality and member...
Aktis Oncology partners Eli Lilly to discover, develop anticancer radiopharmaceuticals Ruchika Sharma26 May 2024 11:30 AM ISTBoston: Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid...
